Michigan Administrative Code
Department - Licensing and Regulatory Affairs
Bureau of Professional Licensing
Board of Pharmacy
Board of Pharmacy - Controlled Substances
Part 1 - GENERAL PROVISIONS
Section R. 338.3102 - Definitions; I to P
Current through Vol. 24-16, September 15, 2024
Rule 2. As used in these rules:
(a) "Inventory" means all stocks in finished form of a controlled substance that are manufactured or otherwise acquired by a licensee, whether in bulk or commercial containers or contained in pharmaceutical preparations in the possession of the licensee.
(b) "Licensee" means a person that is licensed under section 7303 of the code, MCL 333.7303.
(c) "MAPS" means the Michigan automated prescription system.
(d) MAPS claim form" means a form determined by the department that is in the format and includes the information as specified by the ASAP 5.0 Standard for Prescription Drug Monitoring Programs and contains the information specified in R 338.3162b.
(e) "Medical institution" means that term as defined in R 338.486.
(f) "NDC" means a national drug code number that identifies the labeler, product, and package size and is assigned to each drug product listed under section 510 of the FDCA, 21 USC 360.
(g) "Officer" means a federal, state, county, or local law enforcement officer who enforces the laws of this state.
(h) "Patient identifier" means all of the following information about a patient:
(i) "Positive identification" means identification that includes a photograph of an individual in addition to the individual's date of birth. Positive identification includes an identification card issued by a governmental agency.